Resmed Inc
NYSE:RMD

Watchlist Manager
Resmed Inc Logo
Resmed Inc
NYSE:RMD
Watchlist
Price: 213.99 USD 1.63% Market Closed
Market Cap: 31.4B USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

RMD Price Targets Summary
Resmed Inc

Wall Street analysts forecast RMD stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for RMD is 273.86 USD with a low forecast of 196.95 USD and a high forecast of 309.75 USD.

RMD Lowest Forecast
Wall Street Target
196.95 USD
8% Downside
RMD Average Forecast
Wall Street Target
273.86 USD
28% Upside
RMD Highest Forecast
Wall Street Target
309.75 USD
45% Upside
Lowest
Price Target
196.95 USD
8% Downside
Average
Price Target
273.86 USD
28% Upside
Highest
Price Target
309.75 USD
45% Upside
Resmed Inc Competitors:
Price Targets
1789
AK Medical Holdings Ltd
19% Upside
ZBH
Zimmer Biomet Holdings Inc
21% Upside
DXR
Daxor Corp
217% Upside
EW
Edwards Lifesciences Corp
17% Upside
1789
AK Medical Holdings Ltd
19% Upside
ZBH
Zimmer Biomet Holdings Inc
21% Upside
DXR
Daxor Corp
217% Upside
EW
Edwards Lifesciences Corp
17% Upside
PRM
Prim SA
78% Upside
TMDX
Transmedics Group Inc
46% Upside
N
NXTMH
Nexstim Oyj
15% Upside
6960
Fukuda Denshi Co Ltd
19% Upside

Revenue
Forecast

Revenue Estimate
Resmed Inc

For the last 8 years the compound annual growth rate for Resmed Inc's revenue is 12%. The projected CAGR for the next 3 years is 8%.

12%
Past Growth
8%
Estimated Growth
Estimates Accuracy
-1%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Resmed Inc

For the last 8 years the compound annual growth rate for Resmed Inc's operating income is 16%. The projected CAGR for the next 3 years is 14%.

16%
Past Growth
14%
Estimated Growth
Estimates Accuracy
-5%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Resmed Inc

For the last 8 years the compound annual growth rate for Resmed Inc's net income is 14%. The projected CAGR for the next 3 years is 18%.

14%
Past Growth
18%
Estimated Growth
Estimates Accuracy
-11%
Average Miss
What are analyst estimates?

See Also

Summary
RMD intrinsic value, competitors valuation, and company profile.
DCF Valuation
RMD stock valuation using Discount Cash Flow valuation method.
Relative Valuation
RMD stock valuation using valuation multiples.
Wall Street Estimates
RMD price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
RMD stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is RMD's stock price target?
Price Target
273.86 USD

According to Wall Street analysts, the average 1-year price target for RMD is 273.86 USD with a low forecast of 196.95 USD and a high forecast of 309.75 USD.

What is Resmed Inc's Revenue forecast?
Projected CAGR
8%

For the last 8 years the compound annual growth rate for Resmed Inc's revenue is 12%. The projected CAGR for the next 3 years is 8%.

What is Resmed Inc's Operating Income forecast?
Projected CAGR
14%

For the last 8 years the compound annual growth rate for Resmed Inc's operating income is 16%. The projected CAGR for the next 3 years is 14%.

What is Resmed Inc's Net Income forecast?
Projected CAGR
18%

For the last 8 years the compound annual growth rate for Resmed Inc's net income is 14%. The projected CAGR for the next 3 years is 18%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 246,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.